A number of genetic and biotechnological applications are facilitated by the ability to transform Escherichia coli with more than one recombinant plasmid. For example, a plasmid that carries a gene of interest may require that a trans -acting regulatory protein be expressed from a second plasmid in the cell to effectively regulate its expression (9, 16, 29) . In addition, purification of multisubunit complexes, or characterization of the interaction between gene products, can also be facilitated by elevated expression of the interactive components. In E. coli , for example, the Ffh protein interacts with a 4.5S RNA species to form a ribonucleoprotein complex known as the signal recognition particle (SRP) (17, 18) . To better understand the interactions between Ffh and 4.5S RNA we sought to jointly over-express both of the SRP components in E. coli . One strategy to do this was to individually clone ffh and ffs , which encode 4.5S RNA, into cloning vectors that are members of different incompatibility groups and transform both plasmids into the same E. coli strain.
Some of the most commonly used plasmid vectors are derivatives of the ColE1-like plasmid pMB1, including pBR322 (2) , and high copy number versions comprising the pUC (27, 32) and pBluescript ® (Stratagene, La Jolla, CA, USA) family of vectors. Multicopy cloning vectors that are compatible with pMB1 plasmids include those that use the p15A origin of replication ( ori ) such as pACYC177, PACYC184 (4), as well as other derivatives (1) . In general, these plasmids exist at a medium copy number of 15-20 plasmids/chromosome. Also described are cloning vectors derived from pSC101 (13, 28) that are maintained at low copy number (6-8 copies/chromosome). These vectors permit construction of bacterial strains that harbor compatible plasmids. While medium to low copy number vectors may be suitable for many applications, their use can be limiting when high-level expression of a gene product is required. Therefore, to maximize expression of two different gene products we sought to construct new cloning vectors that are compatible with many commonly used plasmids and that replicate at a high copy number. Although replication of ColE1-like plasmids is dependent on DNA polymerase I and their replication is regulated by the interaction of two complementary RNA transcripts, distinct incompatibility groups have been identified (20, 22) . The ColE1-like plasmid RSF1030 (10), for example, is able to co-reside with both pMB1 and p15A-derivative plasmids, as well as with non-ColE1 vectors such as pSC101. The ori from RSF1030 was therefore selected for construction of a series of new cloning vectors.
Wild-type RSF1030 is maintained at a copy number of 15-20 per chromosome equivalent, a copy number that is comparable to pBR322 (6), pA-CYC177 and pACYC184 (4). To construct a cloning vector that replicates at a high copy number yet maintains its compatibility with commonly used cloning vectors, a high copy number mutant of RSF1030 was isolated. An RSF1030 derivative, pST19 (22) , was converted to a high copy number mutant by selecting transformants able to form colonies in the presence of elevated levels of ampicillin and methicillin. An overnight culture of DH5 αtrans -formed with pST19 was plated onto LB agar plates (21) containing 400 µ g/mL ampicillin and 400 µ g/mL methicillin (31) . Several colonies that arose under these selective conditions were screened using a rapid cell lysis procedure (19) to identify transformants that contained elevated quantities of plasmid DNA. A single mutant that yielded significantly more plasmid DNA than cells transformed with pST19 was selected for further analysis.
DNA sequence analysis of a 1.5 kb segment containing the orifrom the high copy number mutant revealed a single base pair alteration located in a region that encodes the RNAII replication primer and the antisense RNAI transcript ( Figure 1A ). Although this mutation does not appear to have been previously reported in selections for high copy number mutants of ColE1 plasmids (7), the location of this mismatch within the REF1030 ori suggests a possible mechanism for increased copy number. It is well established that the copy number of ColE1-like plasmids is regulated by interaction between folded RNAI and RNAII molecules in a way that prevents RNAII from functioning effectively as a primer for replication (14, 15, 25) . Initial interaction between RNAI and RNAII occurs by contact between the loop regions of the folded RNA molecules (the regions I ′ , II ′ and III ′ are shown for RNAI in Figure 1 ) (24) . If this initial interaction is weakened then RNAII can more frequently assume a confirmation required for it to prime the initiation of replication. Figure 1B shows that the RSF1030 high copy number mutation disrupts a G-C intramolecular base pair in the stem region comprising the II ′ structure of the RNAI molecule (20) . This mismatch is positioned so that it would extend a stretch of unpaired bases within the II ′ stem to a total of four. It is reasonable to suggest that this alteration could also disrupt the II ′ loop structure and, as a consequence, weaken the ability of RNAI to interact with the RNAII primer, leading to an increased frequency of initiation of plasmid replication. It is also worthy to note that, although significant homology exists between the RNAI molecules of several ColE1-like plasmids, the high copy number mutation corresponds to a region of RNAI that is unique to RSF1030 (20) . The high copy number RSF1030 mutant was modified to introduce a variety of features to convert it to a series of versatile cloning vectors. Using standard techniques of recombinant DNA (19), a 1.5 kb Bst YI fragment containing the ori from the high copy pST19 mutant was ligated to a 2.3-kb Bgl II fragment from pWSK29 and pWSK30 (28) , creating pDHA29 and pDHA30, respectively ( Figure 2 ). These plasmids impart resistance to high levels of ampicillin (Amp R , 100 µ g/mL). Derivatives of pDHA29 and pDHA30 were also constructed that impart resistance to different antibiotics. The chloramphenicol (Cam R , 20 µ g/mL) derivatives pDHC29 and pDHC30 were constructed by replacing 0.7 kb Dra I fragment containing the β -lactamase gene ( bla ) from pDHA29 and pDHA30 with a similar sized Bsa AI-Bst UI fragment encoding catfrom pSU23 (1), respectively. pDHK29 and pDHK30 are kanamycin resistant derivatives (Kan R , 30 µ g/mL) and were constructed by replacing bla on pDHA29 and pDHA30 with a 1.3 kb Stu I fragment encoding the Kan R determinant ( apt ) from pBSK8 (23), respectively. As shown in Figure 2 , all vectors carry the multiple cloning site and lacZ αfrom pBluescriptII to facilitate screening of recombinant plasmids by blue/white colony color on X-gal. The vectors also carry f1 ori (+) for isolation of single-stranded DNA.
To characterize the cloning vectors, plasmid copy number determinations were made by a modification of the technique described by Wegrzyn et al. (30) . DH5 α(Life Technologies, Gaithersburg, MD, USA) was transformed with pDHA29, pBR322 or pBluescriptIIKS(+) as described (11) and then cotransformed with the pSC101-derivative plasmid pWSK129 (28) . Cultures were grown at 30°C to saturation in the presence of antibiotics, and the cells were lysed by treatment with alkaline lysis solution (19) . Plasmid DNA was resolved directly from the cell lysates by electrophoresis through a 0.8% agarose gel. Following staining with ethidium bromide, the gel image (Figure 3 ) was captured and analyzed by a Gel-Doc ™2000 imaging system (BioRad Laboratories, Hercules, CA, USA) using pWSK129 DNA as an internal standard. Copy number determinations were made by comparing the relative fluorescence of pDHA29 with that of pBR322 and pBluescriptIIKS(+). The copy number of pDHA29 was observed to be 150-200 copies/chromosome, a value somewhat elevated over pUCand pBluescript-derivative plasmids (5) . Similar copy numbers were also observed for the Cam R and Kan R derivative plasmids.
The new cloning vectors were shown to be compatible with pBR322, pBluescriptII, pACYC184 and pWSK129. Different pDH-vectors were transformed into E. coli DH5 αthat had previously been transformed with other cloning vectors encoding different antibiotic resistances. After culturing the transformants in the absence of antibiotic selection overnight (representing approximately 20 generations), cells were plated onto media to select for the RSF1030-derivative transformants. Colonies were subsequently replica plated onto media to screen for the antibiotic resistance encoded by the co-resident plasmid. A typical result indicated that 98% of the population retained both the high copy number plasmid and the second cloning vector. In contrast, plasmids with known incompatibilities showed a nearly complete loss of one of the plasmids. In a typical experiment, only 12% of a population retained two incompatible plasmids when cultured overnight without antibiotics. Two RSF1030-derivatives with different antibiotic resistance markers were also shown to be incompatible with each other (data not shown).
The newly constructed cloning vectors were used to express both components of the E. coli SRP in the same bacterial stain. To accomplish this, a derivative of pDHC29 that carried ffs + was constructed. This plasmid, pDHC29-ffs , was made by introducing a 0.6 kb Hin dIII-BamHI fragment encoding 4.5S RNA from pSB832 (3) into the multiple cloning site of pDHC29. pDHC29-ffs was transformed into a derivative of E. coli MC4100 (21) that also carried pFfh18, a pUC18-based plasmid previously constructed in our laboratory that expresses Ffh. Control plasmids were also assembled by deleting the coding region for either ffs or ffh . pDHC29-ffswas digested with Mlu I and religated to yield pDHC29-∆ ffs . pFfh18 ∆ ffhwas constructed by removing an Eco RV fragment to delete a significant portion of the ffhgene. Two additional plasmids were constructed by inserting ffh + , and the Eco RV deletion derivative into pBR322, yielding pFfh322 and pFfh322 ∆ ffh , respectively.
The levels of 4.5S RNA expressed from pDHC29-ffswere determined by Northern hybridization. Cultures of MC4100 transformed with pFfh18 along with either pDHC29-ffs or pDHC29-∆ ffs were grown overnight in the presence of both Amp and Cam. Total cellular RNA was isolated from the cultures (Tri-Pure ® Isolation reagent, Roche Molecular Biochemicals, Indianapolis, IN, USA) and resolved by electrophoresis on a 1.3% agarose gel under denaturing conditions (19) . RNA was electrophoretically transferred to a nylon membrane (Hybond ® ; Amersham Pharmacia Biotech, Piscataway, NJ, USA) and probed with a 0.6 kb Hin dIII-BamHI ffs fragment from pSB832 that had been radioactively labeled with [ 32 P]-dATP (HexaLabel ™ DNA labeling kit; MBI-Fermentas, Amherst, NY, USA). Blots were hybridized at 68°C and washed twice at room temperature before exposure by phosphorimager analysis (GS-363 Molecular Imager System™; Bio-Rad Laboratories). As shown in Figure 4 (lanes  3 and 4) , the strain transformed with the pDHC29-ffs + plasmid yielded significantly more 4.5S RNA than the control strain where the RNA was expressed only from a single chromosomal copy of ffs (lanes 1 and 2) . As noted in Figure  4 , the exposure times of the filters had to be adjusted to ensure adequate resolution of both samples.
Western immunoblot analysis was then used to determine the amount of Ffh expressed from various MC4100 transformants. Cultures of different transformants were grown overnight, as described above. Samples were prepared and total cellular proteins were resolved by SDS-PAGE on a 10% gel, using a standard protocol (8) . Proteins were electrophoretically transferred to nitrocellulose, and the filters were reacted with polyclonal antibodies against Ffh as described (8). The decorated proteins were visualized by addition of horseradish peroxidase-conjugated secondary antibodies and substrate (Opti-4CN™; Bio-Rad Laboratories). Although Figure 5 shows that Ffh could be detected in all samples, we observed that significant overproduction of the protein occurred only when 4.5S RNA was also expressed at elevated levels in the cell (compare Figure 5, lanes 2 and  3) . Strikingly, the levels of Ffh expressed from pFfh18 alone were not significantly higher than that seen when Ffh was expressed from the chromosome ( Figure 5, lanes 3 and 5) . Similar results were also seen when Ffh was expressed from a pBR322-derivative plasmid ( Figure 5, lanes 6-9) . This result is consistent with a previous report that the stability of Ffh is dependent on the levels of 4.5S RNA (12) . Apparently, Ffh is unstable when not assembled into the SRP and so significant overproduction of the protein actually requires increased expression of 4.5S RNA.
In conclusion, the pDH-vectors have been constructed that replicate at high copy numbers are compatible with commonly used cloning vectors. Derivatives of these vectors have been used to produce both components of the E. coli SRP and likewise should be useful to increase expression of a number of gene products in combination with products expressed from a number of other cloning vectors. BioTechniques 28:408-412 (March 2000) Adenoviruses have been studied for many decades following the realization they were able to transform rodent cells in culture. Since then, they have served as valuable models for the exploration of the cellular pathways involved in DNA replication, regulation of gene expression and cellular proliferation. In particular, they have played a major role in identifying the Rband p53tu -mor suppressor genes as major regulators of cell growth and as key factors in the genesis of human tumors (1) .
Quantifying Adenoviral Titers by Spectrophotometry
While most adenoviruses are relatively easy to grow, quantifying the number of virus particles and the infectivity of a particular inoculum is much harder. Traditionally, those wanting to accurately quantify the titer of a virus used the plaque-forming assay (6) . However, this assay requires rather lengthy incubations (up to 10 days) and the choice of cell lines that are appropriate for this assay is restrictive. While early passage 293 cells (3) can generally be used successfully, older passage 293 cells give variable results, in our experience.
Other lines such as HeLa cells can be troublesome and many cell lines are not appropriate for this assay. The fluorescent focus assay, while faster than the plaque-forming assay and less dependent on cell type, requires a number of reagents and substantial preliminary optimization (6). Titrating multiple viruses using this assay is both arduous and time consuming and subject to investigator bias because fluorescent foci must be visually identified and counted. Visual identification assumes that a confluent monolayer remains after numerous washes, subsequent to antibody binding steps, and hence is subject to considerable inaccuracies. One of the most widely used assays for quantifying viral titers is the cytopathic effect (CPE) assay (6) . CPE assays rely on the ability of viruses to cause cells to detach from a monolayer or undergo lysis. Generally considered the most convenient assay and accurate enough for most needs, this assay can be performed on a wide variety of human cell lines.
The CPE assay involves seeding cells into 96-well plates and infecting them with serial dilutions of virus. At an appropriate time after infection, CPE (loss of cell attachment) can be estimated microscopically or, alternatively, the media can be removed and the remaining cells fixed and stained with crystal violet solution. The subsequent CPE is assessed and an estimate of virus titer can be made in terms of the dilution of virus, which generates CPE in a prescribed percentage of cells (e.g., 50%). Several problems associated with this method of quantitation are that fixing and staining of cells can result in loss of the monolayer and, as with fluorescent titration, quantitation by direct vizualization is subject to investigator bias.
Here, we describe a variation of the CPE assay using an inexpensive protein stain and spectrophotometric analysis, which gives an accurate and reproducible quantitation of viral titer that is less subject to investigator bias. Virus is harvested from infected 293 or other cells by centrifuging both floating and trypsinized cells at 500 × gfor 5 min and then resuspending the pellet in 20 mM Tris, pH 7.4. Infectious virus is released by rapidly freezing (in dry ice) and thawing the cell suspension 3 × , removing cellular debris by centrifugation at 500 × gfor 10 min and placing aliquots of the supernatant at -70°C until needed.
We describe here the titration of wild-type adenovirus type 5 (Ad5) and the Ad5 replication defective mutant dl 312, which contains a deletion of much of the E1a coding region (5). However, this technique is equally applicable to any lytic virus or viruses capable of causing detachment from the monolayer. We seeded 3 × 10 4 293 cells into each well of a 96-well plate and left them to attach in 100 µ L of DMEM + 0.5% FBS at 37°C, 10% CO 2 . Serial dilutions of the virus inoculum are made in a further 100 µ L of DMEM + 0.5% FBS and added to the culture when cells have attached. Infected cells are incubated for 3 days at 37°C, 10% CO 2 (although this time should be determined empirically, depending on the cell type and virus used), and the media and dead or floating cells are then removed by aspiration.
Cell loss (CPE) is determined by measuring changes in total protein concentrations in each well. Protein concentration is obtained by adding 200 µ L of BCA™ protein assay reagent (Pierce Chemical, Rockford, IL, USA) to each well, followed by gentle shaking. This reagent contains 0.1 M NaOH and components of the Biuret reaction allowing solubilization of the cell membrane, release of cellular proteins and formation of a purple color proportional to the protein concentration. The plate is agitated for 1 min, the color is allowed to develop by incubating the plate at 37°C and absorbance ascertained by spectrophotometry at 570 nm on an Anthos microtiter plate reader. The average absorbance of several blank wells (containing no cells) is sub -
